| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC3556 |
| Trial ID | NCT05995028 |
| Disease | Mature T-Cell and Nk-Cell Lymphoma | T-Cell Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | 4SCAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Universal 4SCAR7U Targeting CD7-positive Malignancies |
| Year | 2023 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-23002 |
| Cohort 1 | |||||||||
|
|||||||||